Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale-up of direct-acting antiviral treatment.
Palmer AY, Wilkinson A, Aitken C, Dietze P, Dore GJ, Maher L, Sacks-Davis R, Stoove M, Wilson D, Hellard M, Scott N
A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison.
Palmer A, Papaluca T, Stoové M, Winter R, Pedrana A, Hellard M, Wilson D, Thompson A, Scott N, EC Victoria Partnership
Potential health gains in West and Central Africa through savings from lower cost HIV treatment.
Stuart RM, Kelly SL, Martin-Hughes R, Wilson DP
Modelling the impact of reducing control measures on the COVID-19 pandemic in a low transmission setting.
Scott N, Palmer A, Delport D, Abeysuriya R, Stuart R, Kerr CC, Ministry D, Klein D, Sacks-Davis R, Heath K, Hainsworth S, Pedrana A, Stoové M, Wilson D, Hellard ME
COVID-19 Global Infectious Disease Threats Infectious Disease Modelling
Modelling the impact of relaxing COVID-19 control measures during a period of low viral transmission.
Scott N, Palmer A, Delport D, Abeysuriya R, Stuart RM, Kerr CC, Mistry D, Klein DJ, Sacks-Davis R, Heath K, Hainsworth SW, Pedrana A, Stoove M, Wilson D, Hellard ME
COVID-19
Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
Suraratdecha C, Stuart RM, Edwards M, Moore R, Liu N, Wilson DP, Albalak R